Adverse effects and relapse rate in patients with inflammatory bowel disease taking azathioprine versus 5-ASA and azathioprine

被引：0
|
作者：
Shah, JA [1 ]
Edwards, CM [1 ]
Probert, CS [1 ]
机构：
[1] Torbay Hosp, Bristol Royal Infirm, Torquay, England
来源：
GUT | 2006年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
306
引用
收藏
页码：A80 / A80
页数：1
相关论文
共 50 条
  • [21] Effects of azathioprine on outcome of pregnancy in Inflammatory Bowel Disease patients: A prospective study
    Kecili, L.
    Bounab, N.
    Kaddache, N.
    Layaida, K.
    Boucekkine, T.
    Debzi, N.
    Berkane, S.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S259 - S259
  • [22] 5-ASA induced interstitial nephritis in patients with inflammatory bowel disease: a systematic review
    Moss, James G.
    Parry, Christopher M.
    Holt, Richard C. L.
    McWilliam, Stephen J.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)
  • [23] Side Effects of Azathioprine in the Treatment of Chronic Inflammatory Bowel Disease
    Avallone, Eleonora V.
    Pica, Roberta
    Cassieri, Claudio
    De Carolis, Aurora
    Paoluzi, Paolo
    Vernia, Piero
    GASTROENTEROLOGY, 2009, 136 (05) : A681 - A681
  • [24] 5-Aminosalicylate (5-ASA) Induced Nephrotoxicity in Inflammatory Bowel Disease
    So, Kenji
    Bewshea, Claire M.
    Heap, Graham A.
    Muller, Andrew F.
    Delaney, Michael P.
    Daneshmend, Tawfique K.
    Hart, Ailsa L.
    Orchard, Timothy R.
    Irving, Peter M.
    D'Souza, Richard
    Mulgrew, Chris
    Kwan, Jonathan
    Silverberg, Mark S.
    Gearry, Richard B.
    Radford-Smith, Graham
    Watermeyer, Gillian
    D'Inca, Renata
    Annese, Vito
    Tsianos, Epameinondas V.
    Russell, Richard K.
    Wilson, David C.
    Parkes, Miles
    Satsangi, Jack
    Oram, Richard A.
    Weersma, Rinse K.
    Lawrance, Ian C.
    Holden, Arthur L.
    Lees, Charlie W.
    Ahmad, Tariq
    GASTROENTEROLOGY, 2013, 144 (05) : S112 - S112
  • [25] 5-AMINOSALICYLATE (5-ASA) INDUCED NEPHROTOXICITY IN INFLAMMATORY BOWEL DISEASE
    So, K.
    Bewshea, C.
    Heap, G. A.
    Muller, A. F.
    Daneshmend, T. K.
    Hart, A. L.
    Orchard, T. R.
    Irving, P. M.
    Russell, R. K.
    Wilson, D. C.
    Parkes, M.
    Satsangi, J.
    Lees, C. W.
    Ahmad, T.
    GUT, 2013, 62 : A22 - A22
  • [26] Azathioprine side effects in the treatment of chronic inflammatory bowel disease
    Lara, VG
    Calle, JLN
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2001, 93 (12) : 767 - 768
  • [27] PREGNANCY IN INFLAMMATORY BOWEL-DISEASE (IBD) PATIENTS ON AZATHIOPRINE
    ALSTEAD, EM
    RITCHIE, J
    LENNARDJONES, J
    FARTHING, MJG
    CLARK, ML
    GUT, 1989, 30 (05) : A718 - A718
  • [28] Asian experience of azathioprine treatment in inflammatory bowel disease patients
    Thia, T. J. K.
    Ling, K. L.
    Ooi, C. J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2007, 22 : A198 - A198
  • [29] Risk of Relapse After Azathioprine (AZA) Discontinuation in Inflammatory Bowel Disease (IBD) Patients in Maintained Remission
    Iborra, Marisa
    Herreras, Julia
    Bosca-Watts, Marta M.
    Cortes, Xavier
    Navarro, Belen
    Martinez, Maria Teresa Blazquez
    Trejo, Galo A.
    Beltran, Belen
    Nos, Pilar
    GASTROENTEROLOGY, 2016, 150 (04) : S442 - S442
  • [30] Withdrawal of Azathioprine in Inflammatory Bowel Disease Patients Who Sustain Remission: New Risk Factors for Relapse
    Marisa Iborra
    Julia Herreras
    Marta Maia Boscá-Watts
    Xavier Cortés
    Galo Trejo
    Elena Cerrillo
    David Hervás
    Miguel Mínguez
    Belén Beltrán
    Pilar Nos
    Digestive Diseases and Sciences, 2019, 64 : 1612 - 1621
12345